Ashland Inc. (NYSE:ASH – Get Free Report) was the target of a significant increase in short interest in May. As of May 31st, there was short interest totalling 741,600 shares, an increase of 5.7% from the May 15th total of 701,600 shares. Currently, 1.5% of the company’s stock are short sold. Based on an average daily volume of 327,500 shares, the short-interest ratio is presently 2.3 days.
Institutional Trading of Ashland
Several hedge funds and other institutional investors have recently bought and sold shares of ASH. Pathstone Family Office LLC acquired a new stake in Ashland in the 3rd quarter worth about $232,000. HighTower Advisors LLC raised its stake in Ashland by 4.8% in the 3rd quarter. HighTower Advisors LLC now owns 6,945 shares of the basic materials company’s stock worth $565,000 after purchasing an additional 321 shares in the last quarter. Citigroup Inc. raised its position in shares of Ashland by 38.4% in the 3rd quarter. Citigroup Inc. now owns 11,027 shares of the basic materials company’s stock valued at $901,000 after buying an additional 3,058 shares in the last quarter. Kestra Advisory Services LLC raised its position in shares of Ashland by 8.3% in the 3rd quarter. Kestra Advisory Services LLC now owns 4,279 shares of the basic materials company’s stock valued at $350,000 after buying an additional 328 shares in the last quarter. Finally, QRG Capital Management Inc. acquired a new position in shares of Ashland in the 3rd quarter valued at approximately $518,000. Institutional investors and hedge funds own 93.95% of the company’s stock.
Ashland Stock Performance
NYSE ASH opened at $97.59 on Thursday. The firm has a 50-day moving average of $97.64 and a 200-day moving average of $92.01. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.94 and a current ratio of 3.15. The stock has a market cap of $4.89 billion, a PE ratio of 25.89, a P/E/G ratio of 0.95 and a beta of 0.92. Ashland has a 52-week low of $70.82 and a 52-week high of $102.50.
Ashland Increases Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Saturday, June 15th. Shareholders of record on Saturday, June 1st were paid a $0.405 dividend. This is a boost from Ashland’s previous quarterly dividend of $0.39. The ex-dividend date was Friday, May 31st. This represents a $1.62 annualized dividend and a yield of 1.66%. Ashland’s payout ratio is 42.97%.
Analyst Upgrades and Downgrades
ASH has been the subject of a number of analyst reports. Jefferies Financial Group raised shares of Ashland from a “hold” rating to a “buy” rating and raised their target price for the company from $100.00 to $126.00 in a research report on Thursday, March 14th. UBS Group lifted their price objective on shares of Ashland from $114.00 to $116.00 and gave the company a “buy” rating in a research report on Wednesday, May 1st. StockNews.com downgraded shares of Ashland from a “buy” rating to a “hold” rating in a research report on Tuesday, May 21st. Mizuho lifted their price objective on shares of Ashland from $101.00 to $110.00 and gave the company a “buy” rating in a research report on Wednesday, May 1st. Finally, BMO Capital Markets lifted their price objective on shares of Ashland from $97.00 to $105.00 and gave the company a “market perform” rating in a research report on Tuesday, May 7th. One analyst has rated the stock with a sell rating, two have issued a hold rating and six have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $106.44.
Read Our Latest Stock Analysis on ASH
About Ashland
Ashland Inc provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; and nutraceutical solutions comprising products for weight management, joint comfort, stomach and intestinal health, sports nutrition, and general wellness, as well as custom formulation, toll processing, and particle engineering solutions.
See Also
- Five stocks we like better than Ashland
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Outlook Therapeutics: Analysts Forecast Over 500% Stock Upside
- Investing in large cap stocks: Diving into big caps
- Campbell Soup Co. Targets Fiscal Q4 Stock Recovery
- Trading Halts Explained
- Zebra Analysts Upgrade Stock, Forecasting Major Reversal
Receive News & Ratings for Ashland Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ashland and related companies with MarketBeat.com's FREE daily email newsletter.